Ji Z - Search Results

1

Machine-learning based integrating bulk and single-cell RNA sequencing reveals the SLC38A5-CCL5 signaling as a promising target for clear cell renal cell carcinoma treatment.

Chen H, Yang W, Ma L, Li Y, Ji Z. Chen H, et al. Among authors: ji z. Transl Oncol. 2023 Dec;38:101790. doi: 10.1016/j.tranon.2023.101790. Epub 2023 Sep 17. Transl Oncol. 2023. PMID: 37722291 Free PMC article.

2

Bilateral adrenal metastasis of renal cell carcinoma 4 years after radical nephrectomy: A case report and review of literature.

Li Y, Ji Z, Wang D, Xie Y. Li Y, et al. Among authors: ji z. Medicine (Baltimore). 2021 Aug 6;100(31):e26838. doi: 10.1097/MD.0000000000026838. Medicine (Baltimore). 2021. PMID: 34397852 Free PMC article.

3

Development of a nomogram combining multiparametric magnetic resonance imaging and PSA-related parameters to enhance the detection of clinically significant cancer across different region.

Zhou Z, Liang Z, Zuo Y, Zhou Y, Yan W, Wu X, Ji Z, Li H, Hu M, Ma L. Zhou Z, et al. Among authors: ji z. Prostate. 2022 Apr;82(5):556-565. doi: 10.1002/pros.24302. Epub 2022 Jan 31. Prostate. 2022. PMID: 35098557

4

Robot-assisted vs. laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma: a systematic review and meta-analysis based on comparative studies.

Ji R, He Z, Fang S, Yang W, Wei M, Dong J, Xu W, Ji Z. Ji R, et al. Among authors: ji z. Front Oncol. 2022 Aug 3;12:964256. doi: 10.3389/fonc.2022.964256. eCollection 2022. Front Oncol. 2022. PMID: 35992849 Free PMC article.

5

Neoadjuvant immunotherapy and chemoimmunotherapy for stage II-III muscle invasive bladder cancer.

Chen H, Yang W, Xue X, Li Y, Jin Z, Ji Z. Chen H, et al. Among authors: ji z. Front Immunol. 2022 Aug 17;13:986359. doi: 10.3389/fimmu.2022.986359. eCollection 2022. Front Immunol. 2022. PMID: 36059550 Free PMC article.

6

Competitive Risk Model for Specific Mortality Prediction in Patients with Bladder Cancer: A Population-Based Cohort Study with Machine Learning.

Su H, Xue X, Wang Y, Lu Y, Ma C, Ji Z, Su X. Su H, et al. Among authors: ji z. J Oncol. 2022 Aug 25;2022:9577904. doi: 10.1155/2022/9577904. eCollection 2022. J Oncol. 2022. PMID: 36059803 Free PMC article.

7

Machine learning to improve prognosis prediction of metastatic clear-cell renal cell carcinoma treated with cytoreductive nephrectomy and systemic therapy.

Yang W, Ma L, Dong J, Wei M, Ji R, Chen H, Xue X, Li Y, Jin Z, Xu W, Ji Z. Yang W, et al. Among authors: ji r, ji z. Biomol Biomed. 2023 May 1;23(3):471-482. doi: 10.17305/bjbms.2022.8047. Biomol Biomed. 2023. PMID: 36326180 Free PMC article.

8

Integrated Analysis Revealed an Inflammatory Cancer-Associated Fibroblast-Based Subtypes with Promising Implications in Predicting the Prognosis and Immunotherapeutic Response of Bladder Cancer Patients.

Chen H, Yang W, Xue X, Li Y, Jin Z, Ji Z. Chen H, et al. Among authors: ji z. Int J Mol Sci. 2022 Dec 15;23(24):15970. doi: 10.3390/ijms232415970. Int J Mol Sci. 2022. PMID: 36555612 Free PMC article.

9

A comprehensive analysis of the FOX family for predicting kidney renal clear cell carcinoma prognosis and the oncogenic role of FOXG1.

Yang W, Chen H, Ma L, Dong J, Wei M, Xue X, Li Y, Jin Z, Xu W, Ji Z. Yang W, et al. Among authors: ji z. Aging (Albany NY). 2022 Dec 29;14(24):10107-10124. doi: 10.18632/aging.204448. Epub 2022 Dec 29. Aging (Albany NY). 2022. PMID: 36585925 Free PMC article.

10

Advances in Medical Treatment of Primary Aldosteronism.

Li YJ, Ji ZG, Wen J. Li YJ, et al. Chin Med Sci J. 2023 Mar 31;38(1):49-56. doi: 10.24920/004137. Chin Med Sci J. 2023. PMID: 36642703

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,237 results

Search Page

Filters